BKAT Critical Care Practice Exam

The duration of action for Lantus (insulin glargine) and Levemir (insulin detemir) is typically in the range of 18-26 hours. These long-acting insulins are designed to provide a stable and prolonged insulin effect, making them suitable for once-daily administration in many patients with diabetes.

Lantus provides a steady release of insulin over this duration, allowing for consistent blood glucose control without the peaks and valleys associated with shorter-acting insulins. Similarly, Levemir also offers a long duration of action, although its effectiveness can vary based on the patient's individual factors, such as body weight and dosing regimen. The goal of these long-acting insulins is to mimic the basal insulin production of the pancreas, which is essential for maintaining normal glucose levels throughout the day and night.

Understanding the expected duration of action is vital in managing diabetes effectively, as it helps in determining the appropriate dosing schedules and can influence meal planning and other insulin management strategies.